Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PBLS

Parabilis Medicines Inc

Jun 10 • 04:00PM ET

31.60

+11.60 58.00 %

Healthcare • Biotechnology • USA • NASD

Today, 1:01 PMRecord $670M upsized IPO sparks 43.52% surge in PBLS debut

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	-	Shs Outstand	118.75M	Perf Week	-
Market Cap	-	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	-
Enterprise Value	-	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	-
Income	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Sales	-	P/B	-	EPS next Y	-	ROA	-	Short Interest	-	Perf YTD	-
Book/sh	-4.80	P/C	-	EPS next 5Y	-	ROE	-	52W High	- -	Perf Year	-
Cash/sh	-	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	- -	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	- -	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	7.40	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.12	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	-	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	6.12	EPS Q/Q	-	SMA20	0.00%	Beta	-	Target Price	-
Payout	-	Debt/Eq	0.22	Sales Q/Q	-	SMA50	0.00%	Rel Volume	-	Prev Close	20.00
Employees	-	LT Debt/Eq	0.15	Earnings	-	SMA200	0.00%	Avg Volume	-	Price	31.60
IPO	Jun 10, 2026	Option/Short	No / No	EPS/Sales Surpr.	- -	Trades		Volume	5,486,363	Change	58.00%

Jun-09-26 08:22PM

Parabilis Medicines Announces Pricing of Upsized Initial Public Offering

(GlobeNewswire)

Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PBLS

Parabilis Medicines Inc

Upgrade your Finviz experience